BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Sep 27, 2010
 |  BC Week In Review  |  Clinical News  |  Clinical Status

PNT2258: Phase I started

ProNAi began a single-arm, open-label, dose-escalation, U.S. Phase I trial to evaluate daily IV PNT2258 for the first 5 days of a 21-day cycle in 20 patients with advanced solid...

Read the full 128 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >